Dr.rer.nat. Christof Bernemann

Current affiliations

Clinic for Urology

Publications

Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer Bernemann C, Schnoeller TJ, Luedeke M, Steinestel K, Boegemann M, Schrader AJ, Steinestel (2017) In: ((Bitte Journal prüfen)), 71. Research article (journal) \| Peer reviewed \| Published
Direct reprogramming of tumor cells: a basis for novel therapeutic approaches Bluemel L, Huelsewig C, Zaehres H, Schoeler H, Kiesel L, Bernemann C (2014) In: Cancer Research, 74 S(19). Research article (journal) \| Peer reviewed \| Published
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling Bernemann C, Hülswig C, Ruckert C, Schäfer S, Blümel L, Hempel G, Götte M, Greve B, Barth PJ, Kiesel L, Liedtke C (2014) In: Molecular Cancer, 2014(13). doi:10.1186/1476-4598-13-174 Research article (journal) \| Peer reviewed \| Published
Targeting triple-negative breast cancer by conversion into HER2-positive cancer: A novel therapeutic approach. Bernemann C, Huelsewig C, Kiesel L, Liedtke C (2012) In: Journal of Clinical Oncology, 30 S(15). Research article (journal) \| Peer reviewed \| Published

Projects

Diskursprojekt: „zellux.net – Stammzellen im Schlaglicht von Forschung, Medizin, Kirche, Ethik und Recht“

Duration: 01/01/2007 - 30/08/2009

Funded by: Federal Ministry of Research, Technology and Space

Type of project: Participation in federally funded joint project

Prizes

Wissenschaftspreis 2015 (1.Platz) Awarded by: Deutsche Gesellschaft für Seneologie Award given to: Bernemann, Christof Date of awarding: 15/06/2015 Type of distinction: Research award or other distinction
Reisestipendium - COMBATing Breast Cancer-Kongress Awarded by: WSG - Women's Healthcare Study Group Award given to: Blümel, Lena; Kalsing, Rita; Hülsewig, Carolin Announced at: 15/11/2013 Type of distinction: Scholarship
Androgenrezeptor Research Grant Awarded by: Astellas Pharma GmbH Award given to: Bernemann, Christof; Todenhöfer, Tilman Announced at: 15/11/2016 Type of distinction: Research award or other distinction

Doctorates

Studies on Naϊve and Primed Pluripotent Stem Cells
Candidate: Bernemann, Christof | Supervisors: Schöler, Hans R.; Stradal, Theresia; Schlatt, Stefan
Period of time: 01/10/2007 - 13/07/2011
Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster

Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer Bernemann C, Schnoeller TJ, Luedeke M, Steinestel K, Boegemann M, Schrader AJ, Steinestel (2017) In: ((Bitte Journal prüfen)), 71. Research article (journal) \| Peer reviewed \| Published
Direct reprogramming of tumor cells: a basis for novel therapeutic approaches Bluemel L, Huelsewig C, Zaehres H, Schoeler H, Kiesel L, Bernemann C (2014) In: Cancer Research, 74 S(19). Research article (journal) \| Peer reviewed \| Published
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling Bernemann C, Hülswig C, Ruckert C, Schäfer S, Blümel L, Hempel G, Götte M, Greve B, Barth PJ, Kiesel L, Liedtke C (2014) In: Molecular Cancer, 2014(13). doi:10.1186/1476-4598-13-174 Research article (journal) \| Peer reviewed \| Published
Targeting triple-negative breast cancer by conversion into HER2-positive cancer: A novel therapeutic approach. Bernemann C, Huelsewig C, Kiesel L, Liedtke C (2012) In: Journal of Clinical Oncology, 30 S(15). Research article (journal) \| Peer reviewed \| Published